Bezafibrate/Diflunisal

苯扎贝特/二氟尼柳

Report date: 2022/11/25 18:08:28

Base Information

Drug NameBezafibrate/Diflunisal
Drug Alias NameDiflunisal/Bezafibrate二氟尼柳苯扎贝特苯扎贝特二氟尼柳Bezafibrate and DiflunisalDiflunisal and Bezafibrate +[9] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsPeroxisome proliferator activated receptor agonists
TargetsPeroxisome proliferator activated receptorCyclooxygenases
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsYes DiflunisalBezafibrate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZalicus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalicus Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A